RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
193 hedge funds and large institutions have $1.36B invested in Revance Therapeutics, Inc. in 2022 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 79 increasing their positions, 52 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $1.7B → $1.36B (-$341M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
193
Holding in Top 10
2
Calls
$156M
Puts
$57.2M
Top Buyers
| 1 | +$26.4M | |
| 2 | +$17.8M | |
| 3 | +$17.6M | |
| 4 |
BlackRock
New York
|
+$17.4M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$16.2M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$8.54M | |
| 3 | -$8.05M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$7.76M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$7.07M |